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httcense.Abstract Introduction: Tuberculosis (TB), the single most frequent infectious cause of death
worldwide, also is a major cause of pleural effusion, which in TB usually has lymphocytic and exu-
dative characteristics. Differential diagnosis between TB and nontuberculous pleural effusion can
be sometimes difﬁcult, representing a critically important clinical problem.
Aim of the work: To evaluate the clinical utility of pleural IFN-c level in pleural ﬂuid for diag-
nosing tuberculous pleuritis.
Subject and methods: The study was conducted in kasr El-Aini hospital, Cairo University in the
period from January 2011 to January 2012. It was carried on 40 patients. The patients included in
the study were classiﬁed into group (included 20 cases with tuberculous pleural effusion) and group
II (included 20 cases with non tuberculous pleural effusion). All patients were subjected for com-
plete history taking and clinical examination, chest X-rays PA and lateral views, pleural ﬂuid aspi-
ration and analysis.
Result: Our results demonstrate that the pleural ﬂuid concentrations of ADA, INF-c in patients
with tuberculous pleural effusions are signiﬁcantly higher than in other effusions. Most impor-
tantly, ROC analysis clearly demonstrated ADA to be more sensitive and speciﬁc than INF-c
for diagnosis of tuberculous pleuritis.
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Open access under CC BY-NC-ND license.nase; INF, interferon; ROC,
berculosis.
01001414949.
(Assem F. Elessawy).
e Egyptian Society of Chest
g by Elsevier
of Chest Diseases and Tuberculos
p://dx.doi.org/10.1016/j.ejcdt.2012.0Introduction
Worldwide, tuberculosis (TB) is the single most frequent cause
of death by an infectious agent [1]. TB also is a major cause of
pleural effusion; tuberculous effusions usually are lymphocytic
and exudative. The diagnosis of tuberculous pleuritis should be
considered in any patient with an exudative pleural effusion.
Management of patients with tuberculous pleuritis who haveis. Production and hosting by Elsevier B.V.
9.003
372 N.A. Helmy et al.acquired pleural effusion requires an effective treatment plan
based on timely and accurate diagnostic information.
The diagnosis of tuberculous pleuritis commonly is made
from observation of granulomas in pleural biopsy specimens
or a culture ﬁnding positive for Mycobacterium tuberculosis
from pleural tissue or pleural ﬂuid. However, sensitivity of
these methods is sufﬁciently low that even when histopathol-
ogy and culture are combined, the diagnosis can be uncertain
or missed in ‘‘negative’’ cases [2,3]. While repeating invasive
diagnostic procedures ultimately may yield positive results,
such an approach places patients at increased risk of complica-
tions and also increases costs. A reliable clinical marker pro-
viding physicians with rapid and accurate diagnosis of
tuberculous pleuritis is greatly needed.
A variety of biological markers have been proposed to aid in
the diagnosis of tuberculous pleuritis, including increased pleu-
ral ﬂuid concentrations of adenosine deaminase (ADA), [4–6]
interferon (INF)-c, [7–13]. However, which of these markers is
most useful for diagnosis of tuberculous pleuritis has not been
determined. Here we studied 40 patients with pleural effusion
to determine whether ADA, INF-c concentrations in pleural
ﬂuid shows associations with the cause of pleural effusion.
Materials and methods
Patients
Forty inpatients presenting with pleural effusions who were
admitted to Kasr El-Aini Hospital between January 2011 and
January 2012 were studied. Informed consent was obtained
from the patients. Clinical signs and symptoms, demographic
data, and radiologic results were recorded. Of these 18 men
and 22 women ranging age from 21 to 70 years old, 19 patients
had tuberculous pleurisy, 11 patients had malignant pleuritis, 5
patients had parapneumonic pleural effusions and 5 patients
had pleural effusion with various nontuberculous, nonmalig-
nant etiologies (liver cell failure in 1 patient, metastatic adeno-
carcinoma in 1 patient and undetermined etiology in 3 patients).
Specimen collection and processing
For each subject, at least 40 mL of pleural ﬂuid was collected
in a syringe during thoracentesis. A portion of the sample was
submitted for acid-fast staining, bacteriologic examination,
cytologic examination, and measurement of protein, lactate
dehydrogenase (LDH), and glucose. Another part of the sam-
ple was centrifuged at 2000 rpm for 10 min. The supernatant
was frozen at 20  until assays for markers.
Diagnosis of tuberculous, malignant, and miscellaneous pleural
effusions
Patients were classiﬁed into one of following diagnostic
groups:
A. Tuberculous pleural effusion: These patients were sub-
categorized into two groups to the diagnostic tests for
tuberculosis: (i) patients with granulomas in the pleural
biopsy specimen in the absence of other pleural granu-
lomatous diseases; (ii) patients aged 40 years or younger,
with a constitutional manifestation with either a positive
puriﬁed protein derivative test or at least 95% lympho-
cytes in the pleural ﬂuid. Patients were classiﬁed accord-
ing to the highest group for criteria met.B. Neoplastic pleural effusions: These patients had a cyto-
logic or histologic diagnosis of neoplasm of the pleural
space or a histologic diagnosis of a tumor in another
organ, and no other cause of pleural effusion.
C. Parapneumonic effusions: These patients presented with
cough, fever, and a radiographic pulmonary inﬁltrate
that resolved with antibiotic treatment. Patients with
empyema, deﬁned as pus in the pleural cavity, were
included in this group.
D. Pleural effusions of unknown (nontuberculous) etiology:
Patients with no known cause of pleural effusion who had
nonspeciﬁc pleuritis by pleural biopsy, thoracoscopy.Determination of pleural ﬂuid levels of ADA, INF-c
ADA activity was measured by auto analyzer using commer-
cially available kits. INF-c was measured using commercially
available enzyme-linked immunosorbent assay kits.
Statistical analysis
Quantitative data were presented as mean and standard devia-
tion (SD) values. For parametric data, Student’s t-test was
used for comparisons between mean values of two groups.
One way ANOVA (Analysis of Variance) was used to compare
between mean values of more than two groups. Tukey’s post
hoc test was used for pair-wise comparisons between mean val-
ues when ANOVA test is signiﬁcant.
For non-parametric data, Mann–Whitney U test was used
to compare between two groups. This test is the non-paramet-
ric alternative to Student’s t-test. Kruskal–Wallis test was used
to compare between more than two groups. This test is the
non-parametric alternative to one-way ANOVA. Mann–Whit-
ney U test was used for pair-wise comparisons between the
groups when Kruskal–Wallis test is signiﬁcant.
Qualitative data were presented as frequencies and percent-
ages. Chi-square (·2) test was used for studying the compari-
sons between different qualitative variables.
Spearman’s correlation coefﬁcient was used to determine
signiﬁcant correlations between the different variables.
Receiver operating characteristic (ROC) curve was con-
structed to establish the optimal cut-off points and the likeli-
hood ratios (LRs) of ADA and interferon.
Results
Diagnostic accuracy of ADA
At cut-off point of 30 IU/L, the sensitivity ofADAwas (84.2%),
speciﬁcity was (71.4%) and the diagnostic accuracy was 77.5%.
ROC curve analysis
Interferon
ROC curve analysis of interferon values for the diagnosis of
TB in the present study showed that the optimal cut-off point
was determined at 0.25. The likelihood ratios (LRs) were 1.88
and 0.20 for values above or below this cut-off point.
Diagnostic accuracy of interferon
The sensitivity of interferon was (84.2%), speciﬁcity was
(57.1%) and the diagnostic accuracy was 70%. (see Table 1–5).
Table 1 Mean, standard deviation (SD), frequency, percentage values and results of One-way ANOVA, Tukey’s test and Chi-square
test for comparison between ages and gender distributions in the studied groups.
TB (n= 19) Malignancy (n= 11) Pneumonia (n= 5) Idiopathic (n= 3) Others (n= 2) P-value
Age (mean ± SD) 29.2 ± 12.2b 55.2 ± 11.9a 54.6 ± 11.5a 51.7 ± 16.1a 58.5 ± 2.1a <0.001*
Gender (frequency, %)
Male 9 (47.4) 5 (45.5) 3 (60) 1 (33.3) 0 (0) 0.681
Female 10 (52.6) 6 (54.5) 2 (40) 2 (66.7) 2 (100)
* Signiﬁcant at P 6 0.05, Different letters are statistically signiﬁcantly different according to Tukey’s test.
Table 2 Sensitivity, speciﬁcity, predictive values and diagnos-
tic accuracy of ADA in detecting TB.
ADA TB Total
+ve ve
+ve 16 (true + ve) 6 (false + ve) 22
ve 3 (false ve) 15 (true ve) 18
Total 19 21 40
40.
Table 3 Results of ROC curve analysis for interferon in
diagnosis of TB.
Area under the ROC curve (AUC) 0.713
Standard error 0.085
95% conﬁdence interval 0.548 to 0.845
P-value 0.013*
* Signiﬁcant at P 6 0.05.
Table 4 Sensitivity, speciﬁcity, predictive values and diagnos-
tic accuracy of interferon in detecting TB.
Interferon TB Total
+ve ve
+ve 16 (true + ve) 9 (false + ve) 25
ve 3 (false ve) 12 (true ve) 15
Total 19 21 40
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Differential diagnosis between tuberculous and nontubercu-
lous pleural effusions represents a critical clinical problem.
Conventional methods for diagnosis of pleural tuberculosis
have proven insufﬁcient. Direct examination of pleural ﬂuid
by Ziehl-Neelsen staining requires bacillar densities of
10,000/mL and therefore, has low sensitivity (0–1%) [2].
Although culture is more sensitive (11–50%), 2–6 weeks are re-
quired to grow M tuberculosis, and a minimum of 10–100 via-
ble bacilli are needed. The sensitivity of pleural biopsyreportedly is higher than thoracentesis whether in terms of cul-
ture (39% vs 79%) [2] or histologic evaluation (71–80%) [2,3].
However, biopsy requires greater expertise, is more invasive,
and is subject to sampling error.
Pleural levels of a number of biomarkers have been pro-
posed as aids in the diagnosis of TPE, including those of
ADA, interferon-gamma, interleukin-12, interleukin-18,
immunosuppressive acidic protein, and soluble interleukin-2
receptor, the levels of which are all signiﬁcantly higher in
TPE than in non-TPE [4].
An ideal test for tuberculous pleurisy should be economic,
minimally invasive, of high accuracy, and quick to perform.
The ADA test has been hailed lately as the ideal test for the
diagnosis of TPE. However, this test has some limitations that
should be taken into consideration when facing the challenge
of diagnosing a pleural effusion of unknown origin [5].
ADA activity is found in pathologic conditions other than
TB. Nevertheless, high levels of the enzyme are more strongly
associated with pleural TB, (ADA), released by activated lym-
phocytes, macrophages and neutrophils, is a nonspeciﬁc mar-
ker of inﬂammation. The ADA2 isoenzyme released from
monocytes and macrophages is the predominant contributor
to total ADA [6].
IFN-gamma, a cytokine that exhibits both antiviral and
cytotoxic activities, It is produced by T lymphocytes in re-
sponse to stimulation with speciﬁc antigens or nonspeciﬁc anti-
gens, and is capable of modifying the response of other cells to
the immune system. INF-c is known to activate macrophages,
increasing their bactericidal capacity against M tuberculosis.
Therefore, INF-c detected in pleural ﬂuid may be the result
from stimulation of T lymphocytes by tuberculous antigens [7].
The interferon- c release assays (IGRAs) are technically
more complicated and expensive than established biomarkers
and their diagnostic performance for active TB is highly vari-
able between studies.. In developing countries where the bur-
den of TB is high and cost is a major issue, pleural ﬂuid
IFN-c does not seem to be an attractive means of differentiat-
ing TB from non-TB . In fact, the World Health Organization
Strategic and Technical Advisory Group for Tuberculosis
Table 5 Sensitivity, speciﬁcity, predictive values and diagnostic accuracy of different tests used in detecting TB.
Sensitivity (%) Speciﬁcity (%) PV+ (%) PV (%) Diagnostic accuracy (%)
ADA 84.2 71.4 72.7 83.3 77.5
Interferon 84.2 57.1 64 80 70
374 N.A. Helmy et al.(WHO STAG–TB) has not yet endorsed the use of IGRAs in
resource-limited countries [7].
According to the ﬁnal diagnosis the patients of our work
were classiﬁed into two groups:
Group : (included 20 cases with newly diagnosed TB. Pleu-
ral effusion who did not receive any treatment.
Group II: (included 20 cases with non tuberculous pleural
effusion), which sub classiﬁed into:
Group IIa: included 11 patients with malignant pleural
effusion who did not receive any radiotherapy or
chemotherapy.
Group IIb: included 5 patients with parapneumonic
effusion.
Group IIc: included 4 patients with Pleural effusions of
unknown (nontuberculous) etiology. Patients with no
known cause of pleural effusion who had nonspeciﬁc pleu-
ritis by pleural biopsy, thoracoscopy.
All of the above, subgroups IIa, IIb, IIc were considered as
control cases.
In this study the mean age of tuberculous patients was
29.2 ± 12.2 years while those of malignant patients were
55.2 ± 11.9 years, 54.6 ± 11.5 years in parapneumonic sub-
group and 51.7 ± 16.1 years, so Tuberculous patients showed
the statistically signiﬁcantly lowest mean age these result
agreed with Valdes et al. [8].
Valdes et al. found that the mean age of tuberculous group
was 33.9 ± 13.2 years that of malignant group was
45.5 ± 16.8 years.
In our study the level of ADA activity was the most sensi-
tive method (84.2%) for the diagnosis of pleural TB. The spec-
iﬁcity of ADA activity was 71.4% for pleural TB, ADA
activity had the highest NPV (83.3%).
These result agreed with Greco et al. who found that mea-
surement of ADA activity was the single most sensitive method
(88.1%) for the diagnosis of pleural TB. The speciﬁcity of
ADA activity was 85.7% for conﬁrmed and probable pleural
TB combined, a value that is inferior to but approximates that
of culturing, pleural biopsy, and PCR. Nevertheless, ADA
activity had the highest NPV (88.2%), which remained high
over a range of prevalence from 0.01 to 0.5 [9].
In a study done by Trajman using histopathology as the ref-
erence standard, pleural ﬂuid ADA activity, PCR and immu-
noglobulin (Ig)A-ELISA tests were evaluated in a high TB
incidence country among 77 patients with pleural effusion,
60 of whom had TB pleuritis [10].
ADA activity was the only test that had a signiﬁcantly high-
er sensitivity than histopathological examination [11].
In our work the level of IFN-c was measured in the pleural
ﬂuid, we found that ROC curve analysis of interferon values
for the diagnosis of TPE showed that the optimal cut-off point
was determined at 0.25. The likelihood ratios (LRs) were 1.88
and 0.20 for values above or below this cut-off point, in order.The sensitivity of interferon was (84.2%), speciﬁcity was
(57.1%) and the diagnostic accuracy was 70%.
This result was agreed with Ogawa using 2.5 IU/ml as cut-
off point, had a sensitivity of 44% and speciﬁcity of 60% [12].
In astudy done by Kaled et al. using cutoff point 6.5 IU/ml,
the sensitivity was 89%, speciﬁcity of 83%, accuracy 86% [13].
We reviewed the literatures and found a difference in the
diagnostic capacity of the pleural IFN gamma between differ-
ent study, this might be due to the different cutoff point level
were used and also may be due to inter- laboratory variability.
There have been many reports on the usefulness of ADA
activity and IFN-c level in the diagnosis of pleural TB. These
reports have shown that the range of sensitivity and speciﬁcity
of ADA activity are 69–100% and 72–100%, respectively,
whereas the sensitivity and speciﬁcity of the IFN-c level are
80–100% and 90–100%, respectively [14].
Sharma study comparing the cost-effectiveness of perform-
ing interferon (IFN)-c estimation in comparison to adenosine
deaminase (ADA) for pleural effusion found that even though
it was more sensitive, the cost of using IFN-c for detecting one
additional patient was equivalent to the cost of complete TB
treatment for six patients [15].
In our study we further compared the sensitivity, speciﬁcity
and the area under the ROC curve among ADA and IFN-c in
tuberculous pleural effusion, and this comparison showed that
ADA activity was 84% in sensitivity, 71.4% speciﬁcity, 77.5%
in accuracy and the IFN gamma activity was 84.2% in sensitiv-
ity, 57.1% speciﬁcity, 70% in accuracy, we found that that the
pleural ﬂuid ADA and IFN-c are useful indicators for diagno-
sis of tuberculous pleuritis.
Although studies [16] have shown IFN-c levels to be more
sensitive and speciﬁc than ADA, it is less preferred in resource-
limited settings as it is more expensive and less readily avail-
able compared to .
However, further studies including larger numbers of pa-
tients are needed to verify this result. In addition, results of
testing for these biological markers should be compared with
polymerase chain reaction ﬁndings in pleural ﬂuids.
Conclusion
IGRAs, although potentially useful tools for diagnosing extra-
pulmonary TB, are still not suitable for high- TB burden, low-
resource countries. A possible practical solution would be to
use ADA measurement as the test of choice at the community
level and IFN-c in tertiary referral institutions.
Further studies including larger numbers of patients should
be undertaken conﬁrm this result.References
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